Search

OBJETIVO: Avaliar a função visual e satisfação dos pacientes submetidos à cirurgia de catarata com implante de lente intra-ocular acomodativa e o impacto na sua qualidade de vida. MÉTODOS: Retrospectivamente, foram avaliados questionários aplicados após um ano da cirurgia de 22 pacientes que foram incluídos num estudo clínico para avaliar segurança e eficácia de uma lente intra-ocular de silicone de câmara posterior designada para corrigir visão para longe e perto. RESULTADOS: Do total dos pacientes operados, 16 (73%) eram bilaterais e 6 (27%) unilaterais, com idade média de 70,2 anos. Dos pacientes com implante unilateral, 5 (83,3%) declararam melhora acentuada da visão e 1 (16,7%) referiu máxima melhora. Quanto ao nível de satisfação, 5 (83,3%) ficaram satisfeitos e 1 (16,7%) muito satisfeito com o resultado cirúrgico. A visão noturna foi declarada como sem dificuldade por 3 (50,0%), pouca dificuldade por 2 (33,3%) e dificuldade moderada por 1 (16,7%). No grupo bilateral, 7 (43,8%) consideraram excelente a qualidade da visão para perto, 7 (43,8%) muito boa, 1 (6,2%) adequada e 1 (6,2%) ruim. A visão intermediária foi classificada como excelente por 6 (37,5%), muito boa por 9 (56,3%) e adequada por 1 (6,2%). A qualidade da visão para longe foi considerada excelente por 9 (56,3%), muito boa por 3 (43,8%), adequada por 2 (12,5%) e não muito boa por 2 (12,5%). Em relação à visão noturna 9 (56,3%) declararam não ter dificuldade alguma, 5 (31,2%) pouca dificuldade e 2 (12,5%) dificuldade moderada. CONCLUSÕES: Considerando a propriedade óptica da LIO, a maioria dos pacientes apresentou uma melhora considerável da função visual, sem a necessidade de correção óptica, e, portanto, com impacto positivo na qualidade de vida.PURPOSE: To evaluate the visual function and satisfaction of patients who underwent cataract surgery and were implanted with an accommodative intraocular lens and the impact in their quality of life. METHODS: Retrospectively, questionnaires applied one year after cataract surgery of 22 patients who were included in a clinical trial to evaluate the safety and effectiveness of a silicone multipiece intraocular lens designed to provide distance and near vision were analyzed. RESULTS: Twenty-two patients with mean age of 70.2 years were enrolled in the study. Sixteen (73%) patients received bilateral and 6 (27%) unilateral implants of the unilateral implant group, 5 (83.3%) patients declared marked improvement of vision, 1 (16.7%) referred maximum improvement. Regarding satisfaction, 5 (83.3%) declared to be satisfied and 1 (16.7%) was very satisfied with the results of the surgery in general. Night vision was declared as without difficulty by 3 patients (50.0%), mild difficulty by 2 (33.3%) and moderate difficulty by 1 (16.7%). In the bilateral group, 7 (43.8%) considered near vision to be of excellent quality, 7 (43.8%) very good, 1 (6.2%) adequate and 1 (6.2%) poor. The quality of intermediate vision was classified as excellent by 6 (37.5%) patients, very good by 9 (56.3%) and adequate by 1 (6.2%). The quality of distance vision was considered excellent by 9 (56.3%) patients, very good by 3 (43.8%), adequate by 2 (12.5%) and not very good by 2 (12.5%). Regarding night vision, 9 (56.3%) patients declared no difficulty, 5 (31.2%) mild difficulty and 2 (12.5%) moderate difficulty. CONCLUSION: Considering IOL optical property, most patients presented important improvement of visual function, without need to wear spectacles and with positive impact on their quality of life.

OBJETIVO: Avaliar a função visual e satisfação dos pacientes submetidos à cirurgia de catarata com implante de lente intra-ocular acomodativa e o impacto na sua qualidade de vida. MÉTODOS: Retrospectivamente, foram avaliados questionários aplicados após um ano da cirurgia de 22 pacientes que foram incluídos num estudo clínico para avaliar segurança e eficácia de uma lente intra-ocular de silicone de câmara posterior designada para corrigir visão para longe e perto. RESULTADOS: Do total dos pacientes operados, 16 (73%) eram bilaterais e 6 (27%) unilaterais, com idade média de 70,2 anos. Dos pacientes com implante unilateral, 5 (83,3%) declararam melhora acentuada da visão e 1 (16,7%) referiu máxima melhora. Quanto ao nível de satisfação, 5 (83,3%) ficaram satisfeitos e 1 (16,7%) muito satisfeito com o resultado cirúrgico. A visão noturna foi declarada como sem dificuldade por 3 (50,0%), pouca dificuldade por 2 (33,3%) e dificuldade moderada por 1 (16,7%). No grupo bilateral, 7 (43,8%) consideraram excelente a qualidade da visão para perto, 7 (43,8%) muito boa, 1 (6,2%) adequada e 1 (6,2%) ruim. A visão intermediária foi classificada como excelente por 6 (37,5%), muito boa por 9 (56,3%) e adequada por 1 (6,2%). A qualidade da visão para longe foi considerada excelente por 9 (56,3%), muito boa por 3 (43,8%), adequada por 2 (12,5%) e não muito boa por 2 (12,5%). Em relação à visão noturna 9 (56,3%) declararam não ter dificuldade alguma, 5 (31,2%) pouca dificuldade e 2 (12,5%) dificuldade moderada. CONCLUSÕES: Considerando a propriedade óptica da LIO, a maioria dos pacientes apresentou uma melhora considerável da função visual, sem a necessidade de correção óptica, e, portanto, com impacto positivo na qualidade de vida. PURPOSE: To evaluate the visual function and satisfaction of patients who underwent cataract surgery and were implanted with an accommodative intraocular lens and the impact in their quality of life. METHODS: Retrospectively, questionnaires applied one year after cataract surgery of 22 patients who were included in a clinical trial to evaluate the safety and effectiveness of a silicone multipiece intraocular lens designed to provide distance and near vision were analyzed. RESULTS: Twenty-two patients with mean age of 70.2 years were enrolled in the study. Sixteen (73%) patients received bilateral and 6 (27%) unilateral implants of the unilateral implant group, 5 (83.3%) patients declared marked improvement of vision, 1 (16.7%) referred maximum improvement. Regarding satisfaction, 5 (83.3%) declared to be satisfied and 1 (16.7%) was very satisfied with the results of the surgery in general. Night vision was declared as without difficulty by 3 patients (50.0%), mild difficulty by 2 (33.3%) and moderate difficulty by 1 (16.7%). In the bilateral group, 7 (43.8%) considered near vision to be of excellent quality, 7 (43.8%) very good, 1 (6.2%) adequate and 1 (6.2%) poor. The quality of intermediate vision was classified as excellent by 6 (37.5%) patients, very good by 9 (56.3%) and adequate by 1 (6.2%). The quality of distance vision was considered excellent by 9 (56.3%) patients, very good by 3 (43.8%), adequate by 2 (12.5%) and not very good by 2 (12.5%). Regarding night vision, 9 (56.3%) patients declared no difficulty, 5 (31.2%) mild difficulty and 2 (12.5%) moderate difficulty. CONCLUSION: Considering IOL optical property, most patients presented important improvement of visual function, without need to wear spectacles and with positive impact on their quality of life. Universidade Federal de São Paulo (UNIFESP) Departamento de Oftalmologia Setor de Pesquisa Clínica Universidade Federal de São Paulo (UNIFESP) Instituto da Catarata Departamento de Oftalmologia Universidade Federal de São Paulo (UNIFESP) Departamento de Oftalmologia Setor de Cirurgia Experimental Universidade Federal de São Paulo (UNIFESP) Departamento de Oftalmologia UNIFESP, Depto. de Oftalmologia Setor de Pesquisa Clínica UNIFESP, Instituto da Catarata Depto. de Oftalmologia UNIFESP, Depto. de Oftalmologia Setor de Cirurgia Experimental UNIFESP, Depto. de Oftalmologia SciELO

PURPOSE: To relate the outcomes of 7 eyes of 7 patients in which a dexamethasone 0.7 mg implant (Ozurdex®) was placed inside the capsule bag after phacoemulsification and intraocular lens (IOL) implantation and compare with the fellow eyes, that were operated by the same technique and received dexamethasone eyedrops in the post-operatory. METHODS: Report review of 7 eyes of 7 patients who received dexamethasone 0.7 mg implant after phacoemulsification and IOL, comparing them to the fellow eyes. All the patients underwent bilateral cataract surgery, with one month interval, by the same technique and by experienced surgeons, without complications. Post operatory medication consisted of moxifloxacin eye drops for all the 14 eyes and topic dexamethasone for the 7 eyes that did not received the implant. RESULTS: Nuclear cataract classification (according to LOCS III) was 3.28 ± 0.69 in the implant eye group and 3.14 ± 0.83 in the fellow eye group. Postoperative best spectacle correct visual acuity (BSCVA) was 0.85 ± 0.12 and 0.87 ± 0.13, respectively in the implant and fellow eye groups. The intraocular pressure remained stable and similar to the pre-operative measurements. Anterior chamber reaction and cornea edema were similar in both groups in the follow-up. Two of the four no sutured pellet migrated to the anterior chamber during the first post-operative week and had to be repositioned. Another no sutured pellet dislocated and remained partially inside the capsule bag. The 3 patients with IOL haptic-sutured pellet had no complications. CONCLUSIONS: In the present study, dexamethasone 0.7mg implant were effective in controlling the inflammation after phacoemulsification and IOL implantation, with no significant side effects.

PURPOSE: To compare the visual performance in the Pseudophakie eye and the phakic eye in four patients who underwent unilateral intraocular lens (IOL) implantation. METHODS: Four patients presenting with unilateral cataract underwent ReSTOR (Alcon Laboratories, Ft Worth, Tex) IOL implantation in their nondominant eye, targeting emmetropia. RESULTS: Uncorrected near visual acuity was >20/32 in all operated eyes and best spectacle-corrected distance visual acuity was 20/16 for two eyes, 20/25 for one eye, and 20/32 for one eye. Reading speed was similar between the eyes, but not for critical print size. Contrast sensitivity was lower in the Pseudophakie eyes. Wavefront analysis showed no considerable difference in total high order aberrations, coma, and spherical aberration between eyes for all patients. CONCLUSIONS: In young patients with unilateral cataract surgery, unilateral multifocal IOL implantation provides satisfactory visual acuity and may be considered an alternative treatment option in this patient population. [J Refract Surg. 2006;22:303-305.]